Vaccination in early life: Standing up to the challenges

Current Opinion in Immunology

Volumn 41, Issue , 2016, Pages 1-8

  Mohr, Elodie ^a   Siegrist, Claire Anne ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BCG VACCINE; CORD FACTOR; CURDLAN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; MIFAMURTIDE; PHOSPHORYL LIPID A; TOLL LIKE RECEPTOR AGONIST; WART VIRUS VACCINE; ZYMOSAN; IMMUNOLOGICAL ADJUVANT; VACCINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; DRUG EFFICACY; EARLY INTERVENTION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREGULATION; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PLASMA CELL; REVIEW; TH1 CELL; TH2 CELL; VACCINATION; VACCINE PRODUCTION; VIRUS IMMUNITY; AGING; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; AGING; HUMANS; VACCINATION; VACCINES;

EID: 84963579211     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.04.004     Document Type: Review

References (68)

1. ACIP Immunization Schedules for Persons Age Birth through 18 Years 2015-2016, http://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html.
2. Rts S.C.T.P. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med 2014, 11:e1001685.
3. Ghazal P., Dickinson P., Smith C.L. Early life response to infection. Curr Opin Infect Dis 2013, 26:213-218.
4. Dowling D.J., Levy O. Ontogeny of early life immunity. Trends Immunol 2014, 35:299-310.
5. Ndure J., Flanagan K.L. Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol 2014, 5:477.
6. Gervassi A.L., Horton H. Is infant immunity actively suppressed or immature?. Virology (Auckl) 2014, 1-9.
7. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009, 30:585-591.
8. Wang G., Miyahara Y., Guo Z., Khattar M., Stepkowski S.M., Chen W. "Default" generation of neonatal regulatory T cells. J Immunol 2010, 185:71-78.
9. Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009, 9:185-194.
10. Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 2014, 5:446.
11. Thome J.J., Bickham K.L., Ohmura Y., Kubota M., Matsuoka N., Gordon C., Granot T., Griesemer A., Lerner H., Kato T., et al. Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat Med 2016, 22:72-77.
12. Adkins B. Heterogeneity in the CD4 T cell compartment and the variability of neonatal immune responsiveness. Curr Immunol Rev 2007, 3:151-159.
13. Duchamp M., Sterlin D., Diabate A., Uring-Lambert B., Guerin-El Khourouj V., Le Mauff B., Monnier D., Malcus C., Labalette M., Picard C. B-cell subpopulations in children: national reference values. Immun Inflamm Dis 2014, 2:131-140.
14. Zhang X., Mozeleski B., Lemoine S., Deriaud E., Lim A., Zhivaki D., Azria E., Le Ray C., Roguet G., Launay O., et al. CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus. Sci Transl Med 2014, 6:238ra272.
15. Ademokun A.A., Dunn-Walters D. Immune responses: primary and secondary. Encyclopedia of Life Sciences 2010, John Wiley & Sons, Ltd, Chichester.
16. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
17. Kollmann T.R., Levy O., Montgomery R.R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012, 37:771-783.
18. Sharma A.A., Jen R., Kan B., Sharma A., Marchant E., Tang A., Gadawski I., Senger C., Skoll A., Turvey S.E., et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1beta production in human monocytes. Eur J Immunol 2015, 45:238-249.
19. Corbett N.P., Blimkie D., Ho K.C., Cai B., Sutherland D.P., Kallos A., Crabtree J., Rein-Weston A., Lavoie P.M., Turvey S.E., et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 2010, 5:e15041.
20. Morris M.C., Surendran N. Neonatal vaccination: challenges and intervention strategies. Neonatology 2016, 109:161-169.
21. Ganapathi L., Van Haren S., Dowling D.J., Bergelson I., Shukla N.M., Malladi S.S., Balakrishna R., Tanji H., Ohto U., Shimizu T., et al. The imidazoquinoline Toll-like receptor-7/8 agonist hybrid-2 potently induces cytokine production by human newborn and adult leukocytes. PLOS ONE 2015, 10:e0134640.
22. Kim D., Niewiesk S. Synergistic induction of interferon alpha through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats. Vaccine 2014, 32:265-270.
23. Lemoine S., Jaron B., Tabka S., Ettreiki C., Deriaud E., Zhivaki D., Le Ray C., Launay O., Majlessi L., Tissieres P., et al. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells. J Allergy Clin Immunol 2015, 136:1355-1368. e1315.
24. Zhang X., Casartelli N., Lemoine S., Mozeleski B., Azria E., Le Ray C., Schwartz O., Launay O., Leclerc C., Lo-Man R. Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings. J Infect Dis 2014, 210:424-434.
25. Zhang X., Lepelley A., Azria E., Lebon P., Roguet G., Schwartz O., Launay O., Leclerc C., Lo-Man R. Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLoS ONE 2013, 8:e52003.
26. Palin A.C., Ramachandran V., Acharya S., Lewis D.B. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol 2013, 190:2682-2691.
27. Hebel K., Weinert S., Kuropka B., Knolle J., Kosak B., Jorch G., Arens C., Krause E., Braun-Dullaeus R.C., Brunner-Weinzierl M.C. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol 2014, 192:5160-5170.
28. Berkley A.M., Hendricks D.W., Simmons K.B., Fink P.J. Recent thymic emigrants and mature naive T cells exhibit differential DNA methylation at key cytokine loci. J Immunol 2013, 190:6180-6186.
29. Paiva R.S., Lino A.C., Bergman M.L., Caramalho I., Sousa A.E., Zelenay S., Demengeot J. Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery. Proc Natl Acad Sci U S A 2013, 110:6494-6499.
30. O'Donnell H., Pham O.H., Li L.X., Atif S.M., Lee S.J., Ravesloot M.M., Stolfi J.L., Nuccio S.P., Broz P., Monack D.M., et al. Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 2014, 40:213-224.
31. Schenten D., Nish S.A., Yu S., Yan X., Lee H.K., Brodsky I., Pasman L., Yordy B., Wunderlich F.T., Bruning J.C., et al. Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells. Immunity 2014, 40:78-90.
32. Pihlgren M., Tougne C., Bozzotti P., Fulurija A., Duchosal M.A., Lambert P.H., Siegrist C.A. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J Immunol 2003, 170:2824-2832.
33. Belnoue E., Pihlgren M., McGaha T.L., Tougne C., Rochat A.F., Bossen C., Schneider P., Huard B., Lambert P.H., Siegrist C.A. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008, 111:2755-2764.
34. Gustafson C.E., Higbee D., Yeckes A.R., Wilson C.C., De Zoeten E.F., Jedlicka P., Janoff E.N. Limited expression of APRIL and its receptors prior to intestinal IgA plasma cell development during human infancy. Mucosal Immunol 2014, 7:467-477.
35. Mastelic B., Kamath A.T., Fontannaz P., Tougne C., Rochat A.F., Belnoue E., Combescure C., Auderset F., Lambert P.H., Tacchini-Cottier F., et al. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol 2012, 189:5764-5772.
36. Mastelic Gavillet B., Eberhardt C.S., Auderset F., Castellino F., Seubert A., Tregoning J.S., Lambert P.H., de Gregorio E., Del Giudice G., Siegrist C.A. MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life. J Immunol 2015, 194:4836-4845.
37. Debock I., Jaworski K., Chadlaoui H., Delbauve S., Passon N., Twyffels L., Leo O., Flamand V. Neonatal follicular Th cell responses are impaired and modulated by IL-4. J Immunol 2013, 191:1231-1239.
38. Kool M., Fierens K., Lambrecht B.N. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol 2012, 61:927-934.
39. He Y., Zeng M.Y., Yang D., Motro B., Nunez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 2016, 530:354-357.
40. Shi H., Wang Y., Li X., Zhan X., Tang M., Fina M., Su L., Pratt D., Bu C.H., Hildebrand S., et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol 2016, 17:250-258.
41. Schallert N., Pihlgren M., Kovarik J., Roduit C., Tougne C., Bozzotti P., Del Giudice G., Siegrist C.A., Lambert P.H. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur J Immunol 2002, 32:752-760.
42. Coffman R.L., Sher A., Seder R.A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33:492-503.
43. Levy O., Goriely S., Kollmann T.R. Immune response to vaccine adjuvants during the first year of life. Vaccine 2013, 31:2500-2505.
44. Nguyen M., Leuridan E., Zhang T., De Wit D., Willems F., Van Damme P., Goldman M., Goriely S. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 2010, 5:e10407.
45. Bekeredjian-Ding I., Jego G. Toll-like receptors-sentries in the B-cell response. Immunology 2009, 128:311-323.
46. Hou B., Saudan P., Ott G., Wheeler M.L., Ji M., Kuzmich L., Lee L.M., Coffman R.L., Bachmann M.F., DeFranco A.L. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 2011, 34:375-384.
47. Didierlaurent A.M., Morel S., Lockman L., Giannini S.L., Bisteau M., Carlsen H., Kielland A., Vosters O., Vanderheyde N., Schiavetti F., et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 2009, 183:6186-6197.
48. Philbin V.J., Dowling D.J., Gallington L.C., Cortes G., Tan Z., Suter E.E., Chi K.W., Shuckett A., Stoler-Barak L., Tomai M., et al. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J Allergy Clin Immunol 2012, 130:195-204. e199.
49. Didierlaurent A.M., Collignon C., Bourguignon P., Wouters S., Fierens K., Fochesato M., Dendouga N., Langlet C., Malissen B., Lambrecht B.N., et al. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J Immunol 2014, 193:1920-1930.
50. Vasilakos J.P., Tomai M.A. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants. Expert Rev Vaccines 2013, 12:809-819.
51. Levy O., Suter E.E., Miller R.L., Wessels M.R. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006, 108:1284-1290.
52. Bjarnarson S.P., Adarna B.C., Benonisson H., Del Giudice G., Jonsdottir I. The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice. J Immunol 2012, 189:1265-1273.
53. Gracia A., Polewicz M., Halperin S.A., Hancock R.E., Potter A.A., Babiuk L.A., Gerdts V. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine 2011, 29:1595-1604.
54. Lisciandro J.G., Prescott S.L., Nadal-Sims M.G., Devitt C.J., Pomat W., Siba P.M., Tulic M.C., Holt P.G., Strickland D., van den Biggelaar A.H. Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS ONE 2012, 7:e36793.
55. Ostrop J., Jozefowski K., Zimmermann S., Hofmann K., Strasser E., Lepenies B., Lang R. Contribution of MINCLE-SYK signaling to activation of primary human APCs by mycobacterial cord factor and the novel adjuvant TDB. J Immunol 2015, 195:2417-2428.
56. Kamath A.T., Mastelic B., Christensen D., Rochat A.F., Agger E.M., Pinschewer D.D., Andersen P., Lambert P.H., Siegrist C.A. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J Immunol 2012, 188:4828-4837.
57. Kamath A.T., Rochat A.F., Christensen D., Agger E.M., Andersen P., Lambert P.H., Siegrist C.A. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS ONE 2009, 4:e5771.
58. Agger E.M., Rosenkrands I., Hansen J., Brahimi K., Vandahl B.S., Aagaard C., Werninghaus K., Kirschning C., Lang R., Christensen D., et al. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS ONE 2008, 3:e3116.
59. van Dissel J.T., Joosten S.A., Hoff S.T., Soonawala D., Prins C., Hokey D.A., O'Dee D.M., Graves A., Thierry-Carstensen B., Andreasen L.V., et al. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine 2014, 32:7098-7107.
60. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., Newport M.J., Aaby P., Whittle H., Lambert P.H., et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002, 168:919-925.
61. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., Baehner F., Borkowski A., Tsai T.F., Clemens R. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011, 365:1406-1416.
62. Nakaya H.I., Clutterbuck E., Kazmin D., Wang L., Cortese M., Bosinger S.E., Patel N.B., Zak D.E., Aderem A., Dong T., et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A 2016.
63. Vono M., Taccone M., Caccin P., Gallotta M., Donvito G., Falzoni S., Palmieri E., Pallaoro M., Rappuoli R., Di Virgilio F., et al. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc Natl Acad Sci U S A 2013, 110:21095-21100.
64. Honda-Okubo Y., Ong C.H., Petrovsky N. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection. Vaccine 2015, 33:4892-4900.
65. Stassijns J., Bollaerts K., Baay M., Verstraeten T. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children. Vaccine 2016, 34:714-722.
66. Madhi S.A., Cutland C.L., Kuwanda L., Weinberg A., Hugo A., Jones S., Adrian P.V., van Niekerk N., Treurnicht F., Ortiz J.R., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014, 371:918-931.
67. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K., Fry N.K., Miller E., Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014, 384:1521-1528.
68. Dowling D.J., Tan Z., Prokopowicz Z.M., Palmer C.D., Matthews M.A., Dietsch G.N., Hershberg R.M., Levy O. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes. PLoS ONE 2013, 8:e58164.